SANGAMO THERAPEUTICS, INC.: capex
| Value | {"amount": 21155000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | SANGAMO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:48.840967+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/94a1c854-f1bf-43c5-b08b-688a3762f592
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-010788Retrieved: 2026-08-19T09:41:48.840967+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001233/capex/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/94a1c854-f1bf-43c5-b08b-688a3762f592
History
- no predecessors — first report